Tag: Simvastatin

“Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version”

$688 Million Settlement Approved in Merck Case By ROSE BOUBOUSHIAN (CN) – Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version, a federal judge ruled. The complaint, filed in New Jersey federal court in […]